Evidence map›Paper›PMID 25384978›Full record

ArticleThe Journal of biological chemistry2015

Targeted identification of sialoglycoproteins in hypoxic endothelial cells and validation in zebrafish reveal roles for proteins in angiogenesis.

Nicolas Delcourt, Celia Quevedo, Christelle Nonne, Pierre Fons, Donogh O'Brien, Denis Loyaux, Maria Diez, François Autelitano, Jean-Claude Guillemot, Pascual Ferrara and 6 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Nicolas DelcourtFrom Sanofi Research and Development, 195 route d'Espagne, 31000 Toulouse, France, Centre de recherche en Cancérologie de Toulouse, INSERM UMR1037, Université de Toulouse, 20-24 rue du pont Saint-Pierre, 31057 Toulouse, France.
Celia QuevedoBiobide, S. L., Paseo Mikeletegi 58, 20009 San Sebastián-Donostia, Spain, and BBD-BioPhenix S. L.-Bionaturis group, Paseo Mikeletegi 56, 20009 San Sebastián-Donostia, Spain.
Christelle NonneFrom Sanofi Research and Development, 195 route d'Espagne, 31000 Toulouse, France.
Pierre FonsFrom Sanofi Research and Development, 195 route d'Espagne, 31000 Toulouse, France.
Donogh O'BrienDonogh O'Brien BioConsulting, Les Poirioux, 18310 St. Outrille, France.
Denis LoyauxFrom Sanofi Research and Development, 195 route d'Espagne, 31000 Toulouse, France.
Maria DiezBiobide, S. L., Paseo Mikeletegi 58, 20009 San Sebastián-Donostia, Spain, and.
François AutelitanoFrom Sanofi Research and Development, 195 route d'Espagne, 31000 Toulouse, France.
Jean-Claude GuillemotFrom Sanofi Research and Development, 195 route d'Espagne, 31000 Toulouse, France.
Pascual FerraraFrom Sanofi Research and Development, 195 route d'Espagne, 31000 Toulouse, France.
Arantza MurianaBBD-BioPhenix S. L.-Bionaturis group, Paseo Mikeletegi 56, 20009 San Sebastián-Donostia, Spain.
Carlos CallolBiobide, S. L., Paseo Mikeletegi 58, 20009 San Sebastián-Donostia, Spain, and.
Jean-Pascal HéraultFrom Sanofi Research and Development, 195 route d'Espagne, 31000 Toulouse, France.
Jean-Marc HerbertFrom Sanofi Research and Development, 195 route d'Espagne, 31000 Toulouse, France.
Gilles FavreCentre de recherche en Cancérologie de Toulouse, INSERM UMR1037, Université de Toulouse, 20-24 rue du pont Saint-Pierre, 31057 Toulouse, France.
Françoise BonoFrom Sanofi Research and Development, 195 route d'Espagne, 31000 Toulouse, France, francoise.bono@sanofi.com.
Sanofi (France) · FRBiosensores (Spain) · ESInserm · FRUniversité de Toulouse · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The formation of new vessels in the tumor, termed angiogenesis, is essential for primary tumor growth and facilitates tumor invasion and metastasis. Hypoxia has been described as one trigger of angiogenesis. Indeed, hypoxia, which is characterized by areas of low oxygen levels, is a hallmark of solid tumors arising from an imbalance between oxygen delivery and consumption. Hypoxic conditions have profound effects on the different components of the tumoral environment. For example, hypoxia is able to activate endothelial cells, leading to angiogenesis but also thereby initiating a cascade of reactions involving neutrophils, smooth muscle cells, and fibroblasts. In addition, hypoxia directly regulates the expression of many genes for which the role and the importance in the tumoral environment remain to be completely elucidated. In this study, we used a method to selectively label sialoglycoproteins to identify new membrane and secreted proteins involved in the adaptative process of endothelial cells by mass spectrometry-based proteomics. We used an in vitro assay under hypoxic condition to observe an increase of protein expression or modifications of glycosylation. Then the function of the identified proteins was assessed in a vasculogenesis assay in vivo by using a morpholino strategy in zebrafish. First, our approach was validated by the identification of sialoglycoproteins such as CD105, neuropilin-1, and CLEC14A, which have already been described as playing key roles in angiogenesis. Second, we identified several new proteins regulated by hypoxia and demonstrated for the first time the pivotal role of GLUT-1, TMEM16F, and SDF4 in angiogenesis.

Indexed as

Neovascularization, PhysiologicProtein Processing, Post-TranslationalAdaptation, PhysiologicalAnimalsAnoctaminsAntigens, CDCalcium-Binding ProteinsCell Adhesion MoleculesCell HypoxiaEndoglinGlucose Transporter Type 1GlycoproteinsGlycosylationHuman Umbilical Vein Endothelial CellsLectins, C-TypeNeuropilin-1ANO6 protein, humanAnoctaminsAntigens, CDCalcium-Binding ProteinsCell Adhesion MoleculesCLEC14A protein, humanEndoglinENG protein, humanGlucose Transporter Type 1GlycoproteinsLectins, C-TypeNeuropilin-1Phospholipid Transfer ProteinsProteomeReceptors, Cell SurfaceSDF4 protein, humanSialoglycoproteinsAdhesion ReceptorAngiogenesisEndothelial CellHypoxiaVascular BiologyZebrafish

Identifiers

PMID25384978
PMCPMC4319010
OpenAlexW2084658212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.